33236-61-2

Basic information

• Product Name: 1-(3,4-dimethoxyphenyl)-N-methylpropan-2-amine
• Synonyms: 1-(3,4-dimethoxyphenyl)-N-methylpropan-2-amine
• CAS NO: 33236-61-2
• Molecular Weight: 209.288
• Mol File: 33236-61-2.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: 1-(3,4-dimethoxyphenyl)-N-methylpropan-2-amine(CAS DataBase Reference)
• NIST Chemistry Reference: 1-(3,4-dimethoxyphenyl)-N-methylpropan-2-amine(33236-61-2)
• EPA Substance Registry System: 1-(3,4-dimethoxyphenyl)-N-methylpropan-2-amine(33236-61-2)

Safety Data

• Hazardous Substances Data: 33236-61-2(Hazardous Substances Data)

Upstream product

• 123-39-7 N-Methylformamide 
• 776-99-8 3,4-dimethoxyphenylacetone 
• 120-26-3 2-(3,4-dimethoxyphenyl)-1-methylethylamine 
• 74-89-5 methylamine 
• 93-40-3 (3,4-Dimethoxyphenyl)acetic acid 
• 37629-53-1 (E)-1,2-dimethoxy-4-(2-nitroprop-1-enyl)benzene 
• 120-14-9 3,4-dimethoxy-benzaldehyde 
• 593-51-1 methylamine hydrochloride 

Downstream Products

• 1446877-03-7 2-(3-(benzyloxy)phenyl)-N-(1-(3,4-dimethoxyphenyl)propan-2-yl)-N-methylacetamide 
• 438625-59-3 3,4-dihydroxymethamphetamine hydrobromide 
• 58379-92-3 N-(1-methyl-2-(3,4-dimethoxy-phenyl)-ethyl)-N-methyl-hydroxylamine 
• 15398-87-5 (+/-)-DHMA 

Relevant articles and documents

Controlling stereoselectivity by enzymatic and chemical means to access enantiomerically pure (1S,3R)-1-benzyl-2,3-dimethyl-1,2,3,4- tetrahydroisoquinoline derivatives

A chemoenzymatic strategy for the synthesis of enantiomerically pure novel alkaloids (1S,3R)-1-benzyl-2,3-dimethyl-1,2,3,4-tetrahydroisoquinolines is presented. The key steps are the biocatalytic stereoselective reductive amination of substituted 1-phenyl

Ecstasy-class derivatives, immunogens, and antibodies and their use in detecting ecstasy-class drugs

The present invention comprises novel analogs of ecstasy-class compounds and novel ecstasy-class immunogens leashed out of, i.e., derived from, the methylenedioxy position. The invention also comprises unique monoclonal antibodies generated using MDO-leashed MDMA immunogens as well as unique conjugates and tracers. These antibodies, conjugates, and tracers are useful in immunoassays for the detection of ecstasy-class compounds in biological fluids.